AI could help doctors pick the right treatment for early liver cancer
NCT ID NCT07582419
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study will test whether artificial intelligence (AI) can help doctors choose between surgery or a less invasive procedure (microwave ablation) for people with early-stage liver cancer. About 1,400 participants will have their ultrasound and MRI scans analyzed by a computer model to predict which treatment is less likely to lead to cancer returning within two years. The goal is to make treatment decisions more personalized and reduce the chance of early recurrence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Hospital of jilin University
Changchun, Jilin, China
Conditions
Explore the condition pages connected to this study.